Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations
- 31 March 1996
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 111 (3) , 545-553
- https://doi.org/10.1016/s0022-5223(96)70306-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.The Journal of Experimental Medicine, 1994
- Conventional cardiopulmonary bypass in neonates. A physiological approach -10 years of experience at Marie-Lannelongue HospitalPerfusion, 1994
- Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.The Journal of Experimental Medicine, 1993
- Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failureThe Annals of Thoracic Surgery, 1993
- Interleukin‐10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharideEuropean Journal of Immunology, 1993
- Interleukin-10Annual Review of Immunology, 1993
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993
- Interleukin 10: An overviewProgress in Growth Factor Research, 1992
- Anoxia-hyperoxia induces monocyte-derived interleukin-8.Journal of Clinical Investigation, 1992
- Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgeryCritical Care Medicine, 1992